Literature DB >> 19212013

Influence of 5-aminoisoquinolin-1-one (5-AIQ) on neutrophil chemiluminescence in rats with transient and prolonged focal cerebral ischemia and after reperfusion.

S Hendryk1, Z P Czuba, H Jedrzejowska-Szypulka, E Szliszka, V A Phillips, M D Threadgill, W Krol.   

Abstract

Stimulation of neutrophils by different factors increases their oxidative activity and the free radicals produced can report on the degree of activation. Poly(adenosine 5'-diphosphate ribose)polymerase-1 (PARP-1), a nuclear enzyme activated by strand breaks in DNA, plays an important role in the tissue injury associated with ischaemia-reperfusion injury and inflammation. 5-aminoisoquinolin-1-one (5-AIQ) is a potent inhibitor of PARP-1 activity in vitro and in vivo in rats. Acute (80 min) and prolonged (24h) focal cerebral ischaemia was induced in rats by obstruction of the median cerebral artery, with or without reperfusion, with or without administration of 5-AIQ. The oxidative activity of neutrophils was measured by chemiluminescence. Administration of 5-AIQ.HCl (3.0 mg kg(-1) b.w. - i.v.) caused a significant decrease in the oxidative activity of neutrophils in the group which had experienced chronic ischaemia for 24h but had no significant effect in the group which had received 80 min ischaemia, when compared to the control group. Increase of the oxidative activity of neutrophils was confirmed in rats with prolonged cerebral ischaemia, followed by reperfusion. 5-AIQ probably may decrease this activity through inhibition of PARP-1 in focus of local ischaemia as well as hence lowering the expression of inflammatory mediators by activated neutrophils.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19212013

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  3 in total

1.  Neuroprotective Effects of Poly(ADP-ribose)polymerase Inhibitor Olaparib in Transient Cerebral Ischemia.

Authors:  Fei Teng; Ling Zhu; Junhui Su; Xi Zhang; Ning Li; Zhiyu Nie; Lingjing Jin
Journal:  Neurochem Res       Date:  2016-02-11       Impact factor: 3.996

Review 2.  The potential of PARP inhibitors in neuro-oncology.

Authors:  Ross Carruthers; Anthony J Chalmers
Journal:  CNS Oncol       Date:  2012-09

3.  Antidepressant-Like Actions of Inhibitors of Poly(ADP-Ribose) Polymerase in Rodent Models.

Authors:  Gregory A Ordway; Attila Szebeni; Liza J Hernandez; Jessica D Crawford; Katalin Szebeni; Michelle J Chandley; Katherine C Burgess; Corwin Miller; Erol Bakkalbasi; Russell W Brown
Journal:  Int J Neuropsychopharmacol       Date:  2017-12-01       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.